Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-018063

Chief Medical Officer sold 17,503 shares at an average $20.60 ($360,572)

  • Chief Medical Officer acquired 20,183 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Eisner Mark Chief Medical Officer 2023-03-08 Sale −7,363 $21.16 $155,771 165,133 D
Eisner Mark Chief Medical Officer 2023-03-08 Grant or award +7,732 172,865 D
Eisner Mark Chief Medical Officer 2023-03-08 Grant or award +12,451 185,316 D
Eisner Mark Chief Medical Officer 2023-03-10 Sale −3,885 $20.20 $78,467 181,431 D
Eisner Mark Chief Medical Officer 2023-03-10 Sale −6,255 $20.20 $126,334 175,176 D
Open-market sales · 17,503 sh · avg $20.60 · $360,572
Loading xslF345X03/doc4.xml…